Health2Sync Deepens Reach and Partnerships in South Korea with Growing Adoption of its Digital Disease Management Platform ...

Singapore's opposition leader Pritam Singh has been found guilty of lying under oath to a parliamentary committee. A court imposed the maximum fine of S$7,000 ($5,223; £4,148) for each of two ...

Novartis Singapore provided funding to Ipsos Pte Ltd Singapore for ... AstraZeneca, Kowa, Novartis, Pfizer, Sanofi and Regeneron. The remaining authors declare that the research was conducted in the ...

Credit: Shutterstock / Saiful52. Johnson and Johnson (J&J) has announced the cancellation of its Phase III E.mbrace study examining Sanofi’s investigational vaccine for extraintestinal pathogenic ...

In this article, we are going to take a look at where Sanofi (NASDAQ:SNY) stands against the other ... Regionally, developed Asia, which includes Japan, Hong Kong, Australia, South Korea, and ...

SINGAPORE – Polytechnics have been buzzing with excitement, hosting their open houses to give prospective students a look at the options in their post-secondary educational journey. The Straits ...

Before the Mobile plans in Singapore used to be characterised by contract plans with handset subsidies. These plans package both the mobile data and the handset as part of the monthly fee, which pays ...

SINGAPORE – Tourism spending in Singapore in 2024 is on track to hit an all-time high, surpassing the pre-pandemic high of $27.7 billion in 2019, said the Singapore Tourism Board (STB) on Feb 4 ...

L’Oreal OR0.83%increase; green up pointing triangle will sell part of its stake in Sanofi SAN-0.46%decrease; red down pointing triangle back to the French pharmaceutical company for 3 billion ...

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

AdvanCell has secured $112 million in a Sanofi Ventures-backed series C funding round as the Australian radiopharma company takes its lead candidate through a prostate cancer trial. The Pb-212 ...

Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L'Oréal, the first of multiple share buybacks the French drugmaker has planned for 2025. L'Oréal was selling 29,556,650 ...